• CHANG TSI
  Insights

  July09

  2026

  Crystal Form Patents Secure Maximum term PTE, Bringing a Major Shift to Pharmaceutical Patent Examination Landscape

  
• CHANG TSI
  Insights

  July07

  2026

  Can a Court-Frozen Trademark Be Subject to a Non-Use Cancellation Action?

  
• CHANG TSI
  Insights

  July03

  2026

  Drug Trial Data Protection Regime in China: Key Provisions and Practical Guidance

  
• CHANG TSI
  Insights

  July02

  2026

  Patent Filing in Hong Kong, Macau and Taiwan: Institutional Differences and Practical Considerations from a Cross-Jurisdictional Protection Perspective

  
• CHANG TSI
  Insights

  July01

  2026

  Taiwan Extends Accelerated Patent Examination Scheme for Female Inventors — Another Year of Opportunity

  
• CHANG TSI
  Insights

  July01

  2026

  China's 2026 Trademark Overhaul: What Changes for Global Brands, and How to Prepare Before 2027

  
• CHANG TSI
  Insights

  June29

  2026

  Key Differences in Design Patent Protection Between China and the United States

  
• CHANG TSI
  Insights

  June26

  2026

  Now Official — China just adopted a sweeping new Trademark Law

  
• CHANG TSI
  Insights

  June22

  2026

  First Recognition as Well-Known Trademark! Full Protection Secured for "UNDER ARMOUR"

  
• CHANG TSI
  Insights

  June16

  2026

  From Innovation to Market Success: Patent Strategies Across the Product Lifecycle

  
• CHANG TSI
  Insights

  June12

  2026

  Trademark Renewal in Brunei

  
• CHANG TSI
  Insights

  June10

  2026

  Parameter-Defined Claims in China: Overview, Challenges, and Opportunities

  
上一页 1 2 3 4 5 6 7 8 9 10 下一页

View More